United States: Regulation Of Health IT: A Risk-Based Approach

Last Updated: May 9 2014
Article by Kimberly J. Gold, Sarah T. Hogan, Ellen L. Janos and Kara Romagnino

The FDA will hold a public workshop on May 13-15, 2014 to discuss the long-awaited report (the "Report") issued on April 3, 2014 by the three federal agencies charged with regulating health information technology ("health IT"), the Food and Drug Administration ("FDA"),1 The Office of the Nation Coordinator for Health Information Technology ("ONC")2 and the Federal Communications Commission ("FCC")3 (collectively, the "Agencies").

Overview of the Report

Congress mandated the development of the Report as part of the 2012 Food and Drug Administration Safety and Innovation Act ("FDASIA"), which requires the Agencies to coordinate their efforts to regulate health IT and to develop and post a report on their websites to further the foregoing.

The Report, Proposed Strategy and Recommendations for a Risk-Based Framework, proposes a strategy and recommendations for regulation of health IT that focus on the potential risks while promoting innovation, protecting patient safety, and avoiding regulatory duplication. The Agencies recognize that the continued development, implementation and use of health IT products have tremendous benefits to the public. Accordingly, the Agencies have set forth in the Report a strategy and recommendations that the Agencies believe are flexible enough to accommodate the rapidly developing health IT field. The Report recommends an approach to foster the development of a culture of safety and quality, leverage standards and best practices, employ industry-led testing and certification and selectively use tools such as voluntary listing, reporting and training to enable the development of a health care environment that is transparent and promotes learning and continual health IT improvement.

Importantly, the Agencies do not call for additional regulation, stating that "we do not believe that regulation should be or needs to be the first approach used to reach this outcome." Rather, the Report suggests the adoption of a limited, narrowly tailored approach that primarily relies on ONC-coordinated activities and private sector capabilities, and that a non-governmental, independent program may be effective in monitoring compliance. The recommendations in the Report include continued interagency cooperation and collaboration, the creation of a public-private safety entity – the Health IT Safety Center – and a risk-based approach to the regulation of health IT.

To guide the analysis of the appropriate amount of oversight, the Report identifies and distinguishes between three types of health IT: (i) administrative health IT (products for billing and claims processing, scheduling and inventory management); (ii) health management health IT (e.g., products for health information and data exchange, some clinical decision support products, provider order entry products and electronic access to clinical results) and (iii) medical device health IT (e.g., products for detection/diagnostics and remote monitoring). The distinction between these three categories represents the Agencies' intent to focus on the functionality of a particular product – rather than the platform (e.g., on-premise, web-based, mobile application, etc.) – as a means for determining the relative risks associated with these products and determining the appropriate recommendations.

The Report sets forth a framework for regulation of health IT that applies mainly to health management health IT. The Agencies conclude that administrative health IT functionalities pose limited or no risk to patient safety and therefore do not require additional oversight. With respect to medical device health IT, the Agencies note that medical device health IT is subject to greater oversight through FDA regulations that already focus on the functional risks of these products, and as such, "no new or additional areas of FDA oversight are needed."

Proposed Strategy and Recommendations: Four Priority Areas

The majority of the Report describes a framework based on the following four key areas, with recommendations for each. The Agencies also seek public comment on certain specific aspects of each area.

1. Promote the use of quality management principles:

  • The Agencies recognize that many providers and users of health IT already apply quality management principles. The Agencies will work with multiple health IT stakeholders (developers, users, regulators, etc.) to develop a comprehensive health IT quality management framework that will ensure safe design, development, implementation, customization and use of health IT. This approach will leverage existing quality management principles and identify areas where new quality management principles can or should be applied.
  • The Agencies view this strategy, rather than a formal regulatory approach, as the appropriate method for advancing a health IT quality framework.
  • The Agencies seek input from the community on certain questions to assist in developing these quality management principles, including the following: What essential quality management principles should apply to health IT? How should they apply to different stakeholders and at different stages of the health IT product life cycle? How do we assure stakeholder accountability for adoption of quality management principles?

2. Identify, develop and adopt standards and best practices:

  • The Report emphasizes that the identification, development and adoption of applicable health IT standards and best practices can help to deliver consistently high quality health IT products and services to consumers. The Report identifies several priority areas of the health IT life cycle to be the focus areas for standards and best practices, including design, development, implementation, customization, maintenance and interoperability.
  • The Agencies seek input on certain questions to assist in identifying, developing and adopting standards and best practices, including: Are the identified priority areas for standards and practices the proper areas of focus? If not, what areas should be prioritized? How can the private sector help facilitate the development and adoption of applicable health IT standards and best practices?

3. Leverage conformity assessment tools:

  • The Agencies identify conformity assessment tools, such as product testing, certification and accreditation, as a means for providing assurance that certain health IT products and services, as well as their providers, meet specified standards or fulfill certain requirements. The Report recommends that these conformity assessment tools should be used and applied with reference to the relative risk, and in a manner that will distinguish high quality products from low quality products.
  • With respect to conformity assessment tools, the Agencies recommend development of non-governmental, independent programs to perform conformity assessments. The Agencies view this strategy rather than a formal regulatory approach as the appropriate method for advancing conformity assessments.
  • The Agencies seek input on many questions related to clarifying the value and role of conformity assessment tools in health IT, including: What conformity assessment tools, if any, should be incorporated into a risk-based health IT framework? How should they apply to different stakeholders and at different stages of the health IT product life cycle? How can adoption of and adherence to conformity assessment programs be promoted? Should interoperability standard(s) be adopted? How should conformance assessment results be communicated to stakeholders? Is there a role for a non-governmental, independent health IT conformity assessment program? Should the ONC Health IT Certification Program be leveraged to protect patient safety through the use of conformity assessment tools?

4. Create an environment of learning and continual improvement:

  • The Report encourages the collaboration of the public and private sectors to develop a culture of safety, transparency, learning, continual improvement and shared responsibility with better-defined accountability. The Report recommends that the various stakeholders report serious health IT-related safety events to a trusted source that can aggregate and analyze information and disseminate findings.
  • The Report recommends the creation of a public-private entity – the Health IT Safety Center – that would identify the governance structures and functions needed for the creation of a sustainable, integrated health IT learning system.
  • The Agencies seek public input on certain questions related to creating an environment of learning and continual improvement, including: What should be the governance structure and functions of the Health IT Safety Center? How can comparative user experiences with health IT be captured and made available to the health IT community and other members of the public to promote learning? What type of safety-related surveillance is appropriate for health IT products categorized as health management functionality? What continued or expanded role(s), if any, should the ONC Health IT Certification Program play in the safety-related surveillance of health IT products?

Focus on Clinical Decision Support

In addition to the recommendations above, the Report sets forth much needed guidance on clinical decision support ("CDS") products. CDS products provide health care providers and patients with information to improve health and health care, such as computerized reminders and alerts for providers and patients. The Report concludes that most CDS functionalities can be categorized as health management health IT and therefore would not be subject to FDA regulation. However, certain types of CDS tools that present higher risks to patients, such as computer-aided detection/diagnostic software, warrant FDA's continued oversight as medical device health IT. The FDA will work with federal and private stakeholders to clarify the types of medical device CDS that should be the focus of FDA's oversight.

With respect to the CDS products that fall within the health management health IT category, the Agencies recommend that health IT stakeholders work together to develop policies for the transparent disclosure of the rules and information sources underlying CDS products. The Agencies seek input from the community in developing such rules, with reference to certain questions, such as: What types of CDS functionality should be subject to the health management health IT framework? Which types should be the focus of FDA oversight? Are there additional safeguards for CDS, such as greater transparency with respect to CDS rules and information sources, that are needed to appropriately balance patient safety and the promotion of innovation? How can the private sector help assure the facilitation of the development, application and adoption of high quality CDS with health management health IT functionality in lieu of a regulatory approach? What role, if any, should government play?

The Agencies are seeking public comments by July 7, 2014 on whether the focus areas identified in the Report are the appropriate ones, and whether the proposed next steps will accomplish the purposes of protecting patient safety, promoting innovation and avoiding regulatory duplication.

Footnotes

1 The FDA is involved in the oversight of health IT because a subset of health IT products meets the statutory definition of "medical device," and as such are subject to regulation of the Federal Food, Drug, and Cosmetic Act. In September 2013, the FDA issued final guidance on the agency's oversight of mobile medical applications.

2 The ONC is the principal federal entity charged with coordination of nationwide efforts to implement and use the most advanced health IT and the electronic exchange of health information.

3 The FCC is the regulatory body charged with overseeing spectrum used by individuals, private organizations, and public safety and health officials.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Kimberly J. Gold
Sarah T. Hogan
Similar Articles
Relevancy Powered by MondaqAI
Sheppard Mullin Richter & Hampton
Drinker Biddle & Reath LLP
Foley Hoag LLP
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Sheppard Mullin Richter & Hampton
Drinker Biddle & Reath LLP
Foley Hoag LLP
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions